13,607 Shares of Celestica, Inc. $CLS Bought by Ibex Wealth Advisors

Ibex Wealth Advisors bought a new position in Celestica, Inc. (NYSE:CLS) (TSE:CLS) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 13,607 shares of the technology company’s stock, valued at approximately $4,918,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CLS. Cibc World Market Inc. bought a new position in shares of Celestica during the second quarter valued at approximately $757,811,000. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Celestica in the 2nd quarter worth approximately $674,199,000. Bank of America Corp DE bought a new stake in shares of Celestica in the 2nd quarter worth approximately $444,899,000. The Manufacturers Life Insurance Company bought a new stake in shares of Celestica in the 2nd quarter worth approximately $351,717,000. Finally, Legal & General Group Plc acquired a new position in Celestica during the 2nd quarter valued at approximately $333,588,000. 67.38% of the stock is currently owned by institutional investors and hedge funds.

Top Celestica Stories

These are some of the CLS stories that stood out recently:

• Positive Sentiment: Options activity was unusually high, with traders buying 18,233 call options—about 23% above average. This may indicate increased bullish positioning, though options flows are not a reliable forecast of share performance.
• Neutral Sentiment: Investors have been searching for CLS, but the coverage describes attention rather than a new business catalyst. Investors Heavily Search Celestica, Inc. (CLS): Here is What You Need to Know
• Neutral Sentiment: A comparison with Sanmina notes both companies are expanding AI-infrastructure capabilities, while growth, profitability and valuation may distinguish them. It offers competitive context but no clear near-term catalyst for CLS. CLS vs. SANM: Which Stock is Better Positioned for the AI Boom?

Analyst Ratings Changes

A number of brokerages recently commented on CLS. Bank of America restated a “buy” rating on shares of Celestica in a research note on Wednesday, July 29th. Wolfe Research raised their target price on Celestica from $425.00 to $475.00 and gave the company an “outperform” rating in a research note on Wednesday, July 29th. Scotiabank initiated coverage on shares of Celestica in a report on Tuesday, August 11th. They set a “sector outperform” rating and a $500.00 price target for the company. TD set a $430.00 price target on shares of Celestica and gave the stock a “buy” rating in a research report on Wednesday, September 16th. Finally, Barclays upped their price target on shares of Celestica from $406.00 to $414.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 28th. Two analysts have rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $445.14.

Insiders Place Their Bets

In related news, CEO Robert Mionis sold 23,396 shares of the company’s stock in a transaction dated Wednesday, September 23rd. The shares were sold at an average price of $364.22, for a total value of $8,521,291.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, President Todd C. Cooper sold 20,118 shares of the company’s stock in a transaction dated Wednesday, September 23rd. The stock was sold at an average price of $360.00, for a total transaction of $7,242,480.00. Following the completion of the sale, the president directly owned 73,252 shares of the company’s stock, valued at $26,370,720. The trade was a 21.55% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.10% of the stock is currently owned by company insiders.

Celestica Stock Performance

Celestica stock traded down $14.14 during mid-day trading on Friday, hitting $239.89. 3,610,264 shares of the company’s stock traded hands, compared to its average volume of 3,812,398. The firm has a 50 day moving average price of $311.43 and a 200 day moving average price of $327.38. The company has a quick ratio of 1.03, a current ratio of 1.61 and a debt-to-equity ratio of 0.13. The company has a market cap of $30.25 billion, a PE ratio of 22.70, a price-to-earnings-growth ratio of 1.78 and a beta of 2.10. Celestica, Inc. has a one year low of $197.50 and a one year high of $474.02.

Celestica (NYSE:CLS) (TSE:CLS) last announced its quarterly earnings results on Monday, October 26th. The technology company reported $3.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.02 by $0.28. Celestica had a return on equity of 33.80% and a net margin of 6.83%. The company had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.39 billion. On average, equities analysts forecast that Celestica, Inc. will post 10.97 EPS for the current year.

Celestica Profile

Celestica Inc. is a global provider of design, manufacturing, and supply chain services for companies across technology and industrial markets. Its work spans product development, engineering, manufacturing, testing, and ongoing product support. The company’s offerings include hardware and infrastructure used in cloud computing and data centers, communications networks, aerospace and defense, industrial equipment, and health technology. It also provides supply chain management and other services to support products throughout their lifecycle.